AxoGen (AXGN) announced positive topline results from a phase 3 study for the Avance Nerve Graft. President, CEO, and Chairman Karen Zaderej weighs in on the tissue product moving into the biological category. Avance Nerve Graft would be used whenever a nerve is cut anywhere on the body and in the peripheral nervous system. This would repair the nerve. Nerve damage can occur from kitchen knives to vehicle accidents to power tools.
21 Nov 2022
The Watch List
17 Feb 2023
The Watch List
22 Jan 2023
Market On Close
23 Jan 2023
The Watch List
31 Jan 2023
The Watch List
20 Jan 2023